Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don W Cleveland

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|November 29, 2012
The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregationAndrew J Holland, Don W Cleveland
EMBO Reports|May 9, 2012
Losing balance: the origin and impact of aneuploidy in cancerAndrew J Holland, Don W Cleveland
Nature Reviews. Neurology|December 17, 2016
Gene therapy: Gene-editing therapy for neurological diseaseMoira A McMahon, Don W Cleveland
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2014
Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS miceChristian S Lobsiger, Don W Cleveland
Nature Medicine|November 9, 2012
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangementsAndrew J Holland, Don W Cleveland
Experimental Neurology|August 27, 2014
Special Issue on amyotrophic lateral sclerosisBryan J Traynor, Don W Cleveland
Current Opinion in Cell Biology|January 17, 2002
Slow axonal transport: fast motors in the slow laneJagesh V Shah, Don W Cleveland
Science (New York, N.Y.)|January 22, 2005
Medicine. Treating neurodegenerative diseases with antibioticsTimothy M Miller, Don W Cleveland
Cancer Cell|August 12, 2008
Beyond genetics: surprising determinants of cell fate in antitumor drugsAndrew J Holland, Don W Cleveland
Cell|March 24, 2009
Rethinking ALS: the FUS about TDP-43Clotilde Lagier-Tourenne, Don W Cleveland
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|November 29, 2012
The deubiquitinase USP44 is a tumor suppressor that protects against chromosome missegregationAndrew J Holland, Don W Cleveland
EMBO Reports|May 9, 2012
Losing balance: the origin and impact of aneuploidy in cancerAndrew J Holland, Don W Cleveland
Nature Reviews. Neurology|December 17, 2016
Gene therapy: Gene-editing therapy for neurological diseaseMoira A McMahon, Don W Cleveland
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2014
Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS miceChristian S Lobsiger, Don W Cleveland
Nature Medicine|November 9, 2012
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangementsAndrew J Holland, Don W Cleveland
Experimental Neurology|August 27, 2014
Special Issue on amyotrophic lateral sclerosisBryan J Traynor, Don W Cleveland
Current Opinion in Cell Biology|January 17, 2002
Slow axonal transport: fast motors in the slow laneJagesh V Shah, Don W Cleveland
Science (New York, N.Y.)|January 22, 2005
Medicine. Treating neurodegenerative diseases with antibioticsTimothy M Miller, Don W Cleveland
Cancer Cell|August 12, 2008
Beyond genetics: surprising determinants of cell fate in antitumor drugsAndrew J Holland, Don W Cleveland
Cell|March 24, 2009
Rethinking ALS: the FUS about TDP-43Clotilde Lagier-Tourenne, Don W Cleveland
Pageof 25